Briefing
CIRCULATE-US: adjuvant chemotherapy assigned from postoperative ctDNA in colon cancer
Phase 2/3 trial that assigns adjuvant chemotherapy according to whether circulating tumor DNA is detected after surgery for colon cancer. ClinicalTrials.gov lists the study as recruiting.
- Design: Phase 2/3 · Recruiting